Mason W - Search Results

1

Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs.

Sharek PJ, Horbar JD, Mason W, Bisarya H, Thurm CW, Suresh G, Gray JE, Edwards WH, Goldmann D, Classen D. Sharek PJ, et al. Among authors: mason w. Pediatrics. 2006 Oct;118(4):1332-40. doi: 10.1542/peds.2006-0565. Pediatrics. 2006. PMID: 17015521

2

Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.

Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ. Takata GS, et al. Among authors: mason w. Pediatrics. 2008 Apr;121(4):e927-35. doi: 10.1542/peds.2007-1779. Pediatrics. 2008. PMID: 18381521

3

Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative.

Jeffries HE, Mason W, Brewer M, Oakes KL, Muñoz EI, Gornick W, Flowers LD, Mullen JE, Gilliam CH, Fustar S, Thurm CW, Logsdon T, Jarvis WR. Jeffries HE, et al. Among authors: mason w. Infect Control Hosp Epidemiol. 2009 Jul;30(7):645-51. doi: 10.1086/598341. Infect Control Hosp Epidemiol. 2009. PMID: 19496731

4

Nosocomial measles infection in a pediatric hospital during a community-wide epidemic.

Rivera ME, Mason WH, Ross LA, Wright HT Jr. Rivera ME, et al. Among authors: mason wh. J Pediatr. 1991 Aug;119(2):183-6. doi: 10.1016/s0022-3476(05)80725-5. J Pediatr. 1991. PMID: 1861204

5

Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media.

Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Takata GS, et al. Among authors: mason w. Pediatrics. 2001 Aug;108(2):239-47. doi: 10.1542/peds.108.2.239. Pediatrics. 2001. PMID: 11483783

6

Risk factors for nonresponse to therapy in Kawasaki disease.

Ashouri N, Takahashi M, Dorey F, Mason W. Ashouri N, et al. Among authors: mason w. J Pediatr. 2008 Sep;153(3):365-8. doi: 10.1016/j.jpeds.2008.03.014. Epub 2008 May 16. J Pediatr. 2008. PMID: 18534243

7

Infliximab treatment for refractory Kawasaki syndrome.

Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Burns JC, et al. J Pediatr. 2005 May;146(5):662-7. doi: 10.1016/j.jpeds.2004.12.022. J Pediatr. 2005. PMID: 15870671

8

Comparative safety and efficacy of two immune globulin products in Kawasaki disease.

Rosenfeld EA, Shulman ST, Corydon KE, Mason W, Takahashi M, Kuroda C. Rosenfeld EA, et al. Among authors: mason w. J Pediatr. 1995 Jun;126(6):1000-3. doi: 10.1016/s0022-3476(95)70233-4. J Pediatr. 1995. PMID: 7776074 Clinical Trial.

9

Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.

Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, Myones BL, Wheeler JG, Ruthazer R, Schlievert PM. Leung DY, et al. J Pediatr. 2002 Jun;140(6):742-6. doi: 10.1067/mpd.2002.123664. J Pediatr. 2002. PMID: 12072880

10

Laryngotracheobronchitis as a complication of measles during an urban epidemic.

Ross LA, Mason WH, Lanson J, Deakers TW, Newth CJ. Ross LA, et al. Among authors: mason wh. J Pediatr. 1992 Oct;121(4):511-5. doi: 10.1016/s0022-3476(05)81136-9. J Pediatr. 1992. PMID: 1403381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,050 results

Search Page